As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles now introduces — liposomes production services to global scientists for a variety of applications. With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos and advanced technical platforms, these new services can help researchers to solve challenges like limited loading capacity of drugs in the Liposome systems, fast clearance and low cell-uptake rate they are facing.
CD Bioparticles is specialized in the formulation of drug encapsulation in the lipid system. With wide coverage of the high purity lipid products and services for the research of lipidomics, CD Bioparticles can offer clients with end-group-functionalized lipids for customized research design and process scale-up and technology transfer from R&D stage to clinical and commercial stages. CD Bioparticles is experienced in addressing the problems researchers facing in the study like limited lipid options in research, nutraceutical, food and pharmaceutical encapsulation systems.
"Our liposomes production services have many key features when compared with others, such as lipid products discovery, development of lipid-DNA complexes for transfection, synthetic MPL derivatives and adjuvants discovery, discovery and development of the competitive inhibitors and metabolites of lipids, and formulations and process scale-up of liposomes from the lab scale to the clinical and commercial stage. Customers' needs always inspire our team to constantly expand our offering portfolio, and we're so glad to offer such services to the research communities to support their programs." said Dr. Jessica Waldorf, chief scientific officer of R&D department of CD Bioparticles.
"CD Bioparticles offers development services in the lipid extraction, separation, and detection, and this new liposomes production service will help scientists out of tedious chemical synthesis, formulation, and purifications. We consistently exceed clients’ expectations by providing them the most efficient, and proactive services to help them complete study projects. CD Bioparticles is dedicated to offering high quality services to scientists, and we will expand more accesses for global customers to help them achieve their research discoveries and goals." said Prof. Jeffrey A. Depaul, M.D., the chief scientific officer of R&D department of CD Bioparticles.
For more detailed information on liposomes production services or to discover more, please contact CD Bioparticles directly at 1-631-619-7922.
About CD Bioparticles
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. It specializes in a range of formulation and drug delivery technologies, from conventional liposomes, PEGylated liposomes for drug delivery to polymer microspheres and nanoparticles for enhanced drug delivery. It provides contract services of drug delivery formulation developments for basic research, formulation feasibility studies, process development and scale-up, formulation characterization, analytical and nonclinical services.
Release ID: 88951407